ATS vs NUVB Comparison

ATS Corp is engaged in planning, designing, building, commissioning and servicing automated manufacturing systems - including automation products and test solutions - for a broadly diversified base of customers. The company focuses in five key markets: life sciences, food & beverage, transportation, consumer products and energy. The Company's operations are reported as one operating segment, Automation Systems, which plans, allocates resources, builds capabilities and implements practices on a world-wide basis. The company has presence in Canada, United States, Germany, Italy, Other Europe, and Other.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.